Hull Associates

Rockland, United States Founded: 2007 • Age: 19 yrs Acquired By Avania
Provider of market access and reimbursement consulting services for biopharma sector

About Hull Associates

Hull Associates is a Healthcare company based in Rockland (United States) founded in 2007, and was acquired by Avania in October 2023. Provider of market access and reimbursement consulting services for biopharma sector. Hull Associates offers products and services including Market Access Services, Strategic Consulting, Clinical Operations, Data Analytics, and Imaging Core Lab. Its focus areas include Biopharma Outsourcing, Consulting, Business and Market Access & HEOR. Its competitors include Target RWE, Secura Bio and STATinMED Research; 1 of its 3 listed competitors has raised funding.

Company details

Hull Associates, founded in 2007 in Rockland, United States, focuses on providing healthcare solutions, biopharma outsourcing, offering consulting services, business, and market access heor. Provider of market access and reimbursement consulting services for biopharma sector. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

Key Metrics

Products & Services of Hull Associates

Hull Associates offers a comprehensive portfolio of products and services, including Market Access Services, Strategic Consulting, Clinical Operations, Data Analytics, and Imaging Core Lab.

Market Access Services
Consulting

Supports global reimbursement strategies for medical devices

Strategic Consulting
Product Development

Assists with planning and innovation in medical technology

Clinical Operations
Operations

Manages trials and data analytics for MedTech products

Data Analytics
Compliance

Provides safety and compliance solutions for healthcare

Imaging Core Lab
Diagnostics

Offers imaging support for medical device evaluations

Investors in Hull Associates

Hull Associates has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Avania Clinical.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Regulatory, clinical trials, and analytic services are provided in healthcare.
1988avaniaclinical.comBrunswick, Australia
Premium access

Investor details for Hull Associates

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Hull Associates

2 dated milestones of Hull Associates across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded Hull Associates is founded.
  2. Exit Acquired by Avania.

Competitors of Hull Associates

Hull Associates has 3 listed competitors in our database, 1 of them funded. They include Target RWE, Secura Bio and STATinMED Research.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
targetrwe.com2017Durham, United States116
Marketing services to the pharmaceutical industry are provided.
securabio.com2018Henderson, United States$55M
Consulting services for market access and health outcomes are provided.
statinmed.com2007Ann Arbor, United States
Healthcare data analytics services provider
Premium access

Detailed competitors of Hull Associates

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Hull Associates (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Hull Associates

Premium access

Complete news archive for Hull Associates

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hull Associates

Hull Associates was founded in 2007.

Hull Associates is headquartered in Rockland, United States. It is registered at Rockland, Maine, United States.

Hull Associates, founded in 2007 in Rockland, United States, focuses on providing healthcare solutions, biopharma outsourcing, offering consulting services, business, and market access heor. Provider of market access and reimbursement consulting services for biopharma sector. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

Hull Associates's top competitors include Target RWE, STATinMED Research and Secura Bio.

Hull Associates offers Market Access Services, Strategic Consulting, Clinical Operations, Data Analytics, and Imaging Core Lab.

Hull Associates has 1 investor. Key investors include Avania Clinical.

Yes. Hull Associates was acquired by Avania in October 2023.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available